We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00267748
Brief Title: Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC)

First Submitted : December 20, 2005
First Submitted that Met QC Criteria : December 20, 2005
First Posted : December 21, 2005 (Estimate)

Results First Submitted : June 23, 2011
Results First Submitted that Met QC Criteria : August 3, 2011
Results First Posted : September 5, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : August 3, 2011
Last Update Posted : September 5, 2011 (Estimate)